tradingkey.logo

Caris Life Sciences Inc

CAI
30.902USD
-0.278-0.89%
取引時間 ET15分遅れの株価
8.69B時価総額
損失額直近12ヶ月PER

Caris Life Sciences Inc

30.902
-0.278-0.89%

詳細情報 Caris Life Sciences Inc 企業名

Caris Life Sciences Inc. is a patient-centric, next-generation artificial intelligence tech bio company and precision medicine provider. The Company develops and commercializes solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Its entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets. Its platform is purpose-built to leverage the convergence of next-generation sequencing (NGS), artificial intelligence (AI) and machine learning (ML) technologies, and high-performance computing. Its purpose-built, proprietary multi-omic profiling solutions capture and analyze molecular information from tissue and blood in a comprehensive manner. Its services for biopharma companies include prospective and retrospective profiling services, and companion diagnostics development.

Caris Life Sciences Incの企業情報

企業コードCAI
会社名Caris Life Sciences Inc
上場日Jun 18, 2025
最高経営責任者「CEO」Mr. David Dean Halbert
従業員数- -
証券種類Ordinary Share
決算期末Jun 18
本社所在地750 West John Carpenter Freeway
都市IRVING
証券取引所NASDAQ Global Select Consolidated
United States of America
郵便番号75039
電話番号18667718946
ウェブサイトhttps://www.carislifesciences.com/
企業コードCAI
上場日Jun 18, 2025
最高経営責任者「CEO」Mr. David Dean Halbert

Caris Life Sciences Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. George H. Poste, Ph.D.
Dr. George H. Poste, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
511.70K
-2.76%
Mr. Luke Power
Mr. Luke Power
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
99.57K
--
Mr. David (Dave) Fredrickson
Mr. David (Dave) Fredrickson
Independent Director
Independent Director
16.13K
--
Mr. Nathan Burns
Mr. Nathan Burns
Independent Director
Independent Director
--
--
Mr. Vijay Mohan
Mr. Vijay Mohan
Independent Director
Independent Director
--
--
Mr. Danny Phillips
Mr. Danny Phillips
Independent Director
Independent Director
--
--
Dr. Lloyd B. Minor, M.D.
Dr. Lloyd B. Minor, M.D.
Independent Director
Independent Director
--
--
Mr. Peter M. Castleman
Mr. Peter M. Castleman
Lead Independent Director
Lead Independent Director
--
--
J. Russel Denton
J. Russel Denton
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
--
--
Dr. Jeffrey L. (Jeff) Vacirca, M.D.
Dr. Jeffrey L. (Jeff) Vacirca, M.D.
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. George H. Poste, Ph.D.
Dr. George H. Poste, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
511.70K
-2.76%
Mr. Luke Power
Mr. Luke Power
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
99.57K
--
Mr. David (Dave) Fredrickson
Mr. David (Dave) Fredrickson
Independent Director
Independent Director
16.13K
--
Mr. Nathan Burns
Mr. Nathan Burns
Independent Director
Independent Director
--
--
Mr. Vijay Mohan
Mr. Vijay Mohan
Independent Director
Independent Director
--
--
Mr. Danny Phillips
Mr. Danny Phillips
Independent Director
Independent Director
--
--

収益内訳

通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025Q2
データなし
地域別USD
会社名
収益
比率
United States
178.18M
98.22%
International
3.22M
1.78%
事業別
地域別
データなし

株主

更新時刻: Tue, Aug 19
更新時刻: Tue, Aug 19
株主統計
種類
株主統計
株主統計
比率
Halbert (David D)
43.65%
Sixth Street Partners, LLC
8.67%
J.H. Whitney Capital Partners, LLC
7.20%
Castleman Peter M
3.69%
Coatue Management, L.L.C.
3.61%
他の
33.18%
株主統計
株主統計
比率
Halbert (David D)
43.65%
Sixth Street Partners, LLC
8.67%
J.H. Whitney Capital Partners, LLC
7.20%
Castleman Peter M
3.69%
Coatue Management, L.L.C.
3.61%
他の
33.18%
種類
株主統計
比率
Individual Investor
48.41%
Investment Advisor
19.16%
Private Equity
10.55%
Hedge Fund
10.43%
Investment Advisor/Hedge Fund
5.41%
Pension Fund
0.56%
Sovereign Wealth Fund
0.13%
Research Firm
0.05%
他の
5.30%

機関投資家保有株

更新時刻: Wed, Jul 2
更新時刻: Wed, Jul 2
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
166
130.17M
46.29%
+128.70M
2025Q2
45
192.42M
69.23%
+189.87M
2025Q1
3
2.55M
0.92%
+2.55M

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
Halbert (David D)
122.76M
43.65%
-141.96K
-0.12%
Aug 11, 2025
Sixth Street Partners, LLC
24.39M
8.67%
+24.39M
--
Jun 30, 2025
J.H. Whitney Capital Partners, LLC
20.26M
7.2%
+20.26M
--
Jun 30, 2025
Castleman Peter M
10.37M
3.69%
+10.34M
+32049.87%
Jun 18, 2025
Coatue Management, L.L.C.
10.14M
3.61%
+10.14M
--
Jun 30, 2025
Fidelity Management & Research Company LLC
8.61M
3.06%
+8.61M
--
Jun 30, 2025
Braidwell LP
7.32M
2.6%
+7.32M
--
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
7.30M
2.6%
+7.30M
--
Jun 30, 2025
T. Rowe Price Associates, Inc.
6.76M
2.4%
+6.76M
--
Jun 30, 2025
Neuberger Berman, LLC
6.24M
2.22%
+6.24M
--
Jun 30, 2025
詳細を見る

関連ETF

更新時刻: Sun, Nov 2
更新時刻: Sun, Nov 2
銘柄名
比率
ARK Genomic Revolution ETF
0.71%
Texas Capital Texas Small Cap Equity Index ETF
0.5%
Renaissance IPO ETF
0.49%
RiverNorth Patriot ETF
0.38%
Franklin Genomic Advancements ETF
0.16%
Invesco Russell 1000 Equal Weight ETF
0.08%
Texas Capital Texas Equity Index ETF
0.05%
T Rowe Price Small-Mid Cap ETF
0.05%
Fidelity Nasdaq Composite Index ETF
0.02%
iShares Global Equity Factor ETF
0.01%
詳細を見る
ARK Genomic Revolution ETF
比率0.71%
Texas Capital Texas Small Cap Equity Index ETF
比率0.5%
Renaissance IPO ETF
比率0.49%
RiverNorth Patriot ETF
比率0.38%
Franklin Genomic Advancements ETF
比率0.16%
Invesco Russell 1000 Equal Weight ETF
比率0.08%
Texas Capital Texas Equity Index ETF
比率0.05%
T Rowe Price Small-Mid Cap ETF
比率0.05%
Fidelity Nasdaq Composite Index ETF
比率0.02%
iShares Global Equity Factor ETF
比率0.01%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
種類
比率
データなし
日付
種類
比率
データなし
KeyAI